查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954299

避孕市場分析及至2035年預測：依類型、產品、服務、技術、應用、劑型、材料類型及最終用戶分類

Contraceptives Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, Form, Material Type, End User
出版日期: | 出版商: Global Insight Services | 英文 354 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計避孕市場規模將從2024年的336億美元成長到2034年的564億美元，年複合成長率約為5.1%。避孕市場涵蓋用於預防懷孕的產品和方法，包括荷爾蒙避孕藥、保險套、子宮內避孕器和節育手術。推動該市場成長的因素包括計劃生育意識的提高、政府措施以及避孕方法技術的進步。對長效可逆避孕方法（LARC）的需求不斷成長以及對女性健康的日益關注，正在推動創新，以確保避孕方法的有效性和安全性。

避孕市場正經歷強勁成長，這主要得益於人們對計劃生育和生殖健康解決方案的日益重視和需求成長。口服避孕藥市場表現突出，其中複方口服避孕藥和僅含孕激素的口服避孕藥因其有效性和易用性而廣受歡迎。注射避孕藥緊隨其後，反映出其在尋求無需每日注射的長期避孕方案的女性中越來越受歡迎。避孕植入的需求也在上升，它能提供長期保護和便利性。男性避孕市場目前尚不成熟，但隨著研發投入的增加，其成長潛力也活性化。非荷爾蒙避孕方法，例如銅子宮內避孕器，正受到尋求無荷爾蒙替代方案族群的青睞。用於生育追蹤和避孕管理的數位健康應用程式正在成為促進用戶參與和持續使用的重要工具。整體而言，隨著技術進步和研發投入的增加推動創新和普及，市場可望進一步擴張。

市場區隔
類型 荷爾蒙、屏障避孕法、避孕器避孕器、節育手術、自然避孕法
產品 保險套、口服避孕藥、注射避孕針、植入避孕器、子宮內避孕器（IUD）、事後緊急避孕藥、陰道環、避孕貼片、殺精劑
服務 計劃生育服務、諮詢服務和教育服務
科技 長效可逆避孕法（LARC）、短效荷爾蒙避孕法、永久性避孕方法
目的 預防和治療
形式 口服、注射、外用、植入式
材料類型 乳膠、非乳膠、聚氨酯
最終用戶 醫院、診所和居家醫療

避孕藥具市場的特徵是市佔率分佈動態變化、定價策略競爭激烈、創新產品層出不窮。在消費者意識不斷提高和社會對計劃生育態度轉變的推動下，該行業正經歷強勁成長。各公司正加大研發投入，推出滿足消費者多元需求的先進避孕解決方案。定價策略競爭激烈，主要企業利用規模經濟優勢提供具成本效益的選擇。旨在拓展產品系列和增強市場滲透率的策略聯盟和夥伴關係也進一步支持了市場發展。避孕藥具市場的競爭異常激烈，主要企業力求透過創新和品牌定位來實現差異化。區域法規結構對市場動態有顯著影響，嚴格的指導方針確保了產品的安全性和有效性。儘管市場由少數主要企業主導，但新參與企業也正在取得顯著進展。北美和歐洲的監管機構持續制定嚴格的標準，影響產品核可時間和打入市場策略。技術進步和對個人化避孕需求的不斷成長預計將推動市場持續成長。

主要趨勢和促進因素：

避孕市場正經歷強勁成長，這主要得益於人們對計劃生育和生殖健康的認知和需求不斷提高。政府主導的各項措施和日益成長的宣傳活動正在推廣避孕措施的使用，提高不同族群的避孕可及性和認知度。包括長效可逆避孕方法（LARCs）在內的創新避孕技術應運而生，以滿足消費者對便利性和有效性的不斷變化的偏好。此外，隨著越來越多的女性尋求對自身生育選擇擁有更大的掌控權，人們對女性健康和賦權的日益重視也促使避孕器的使用率不斷提高。市場正朝著非荷爾蒙避孕方式轉變，這反映了消費者對更安全、更天然的替代方案的需求。此外，遠端醫療和數位健康平台的擴展也促進了人們獲得避孕產品和諮詢服務，尤其是在偏遠地區。在新興經濟體，不斷加快的都市化和生活方式的改變正在推動對避孕解決方案的需求，這為市場帶來了巨大的機會。專注於提供價格合理、易於取得的避孕產品的公司將佔據有利地位，從而獲得可觀的市場佔有率。此外，與醫療機構和非政府組織建立合作關係可以加強分銷網路和推廣工作，確保更多人獲得避孕選擇。在技​​術進步和全球對生殖健康與權利日益關注的推動下，預計該市場將持續成長。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 荷爾蒙
    • 屏障法
    • 子宮內避孕器
    • 節育手術
    • 自然法
  • 市場規模及預測：依產品分類
    • 保險套
    • 口服避孕藥
    • 注射
    • 植入
    • 子宮內避孕器（IUD）
    • 事後緊急避孕藥
    • 陰道環
    • 修補
    • 殺精劑
  • 市場規模及預測：依服務分類
    • 計劃生育服務
    • 諮詢服務
    • 教育服務
  • 市場規模及預測：依技術分類
    • 長效可逆避孕法（LARC）
    • 短效荷爾蒙避孕藥
    • 永久避孕
  • 市場規模及預測：依應用領域分類
    • 預防
    • 治療
  • 市場規模及預測：依類型
    • 口服
    • 注射
    • 外用
    • 嵌入式
  • 市場規模及預測：依材料類型分類
    • 乳膠
    • 非乳膠
    • 聚氨酯
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 診所
    • 居家醫療

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Reckitt Benckiser Group
  • Church & Dwight
  • Mayer Laboratories
  • Mankind Pharma
  • Cupid Limited
  • Fuji Latex Co Ltd
  • HLL Lifecare Limited
  • Veru Inc
  • Okamoto Industries
  • Ansell Limited
  • Sagami Rubber Industries
  • Karex Berhad
  • Thai Nippon Rubber Industry
  • Bio Film Inc
  • Shanghai Dahua Medical Apparatus
  • Sir Richard's Condom Company
  • RFSU AB
  • Caya
  • Bexen Medical
  • Lelo

第9章：關於我們

簡介目錄
Product Code: GIS32245

Contraceptives Market is anticipated to expand from $33.6 billion in 2024 to $56.4 billion by 2034, growing at a CAGR of approximately 5.1%. The Contraceptives Market encompasses products and methods used to prevent pregnancy, including hormonal pills, condoms, intrauterine devices, and sterilization procedures. This market is driven by increasing awareness of family planning, government initiatives, and technological advancements in contraceptive methods. Rising demand for long-acting reversible contraceptives and the growing emphasis on women's health are fueling innovations, ensuring both efficacy and safety.

The Contraceptives Market is experiencing robust growth, driven by increasing awareness and demand for family planning and reproductive health solutions. The oral contraceptives segment leads in performance, with combination pills and progestin-only pills being widely preferred due to their effectiveness and ease of use. The injectable contraceptives segment follows closely, reflecting rising popularity among women seeking long-term solutions without daily administration. The demand for contraceptive implants is also on the rise, offering prolonged protection and convenience. The male contraceptives segment, though currently underdeveloped, shows potential for growth as research and development efforts intensify. Non-hormonal contraceptives, such as copper IUDs, are gaining traction among individuals seeking hormone-free alternatives. Digital health applications for fertility tracking and contraceptive management are emerging as valuable tools, enhancing user engagement and adherence. Overall, the market is poised for expansion, with technological advancements and increasing investments in research and development driving innovation and accessibility.

Market Segmentation
TypeHormonal, Barrier, Intrauterine, Sterilization, Natural
ProductCondoms, Oral Contraceptive Pills, Injectables, Implants, Intrauterine Devices (IUDs), Emergency Contraceptives, Vaginal Rings, Patches, Spermicides
ServicesFamily Planning Services, Counseling Services, Educational Services
TechnologyLong-acting Reversible Contraceptives (LARC), Short-acting Hormonal Methods, Permanent Methods
ApplicationPreventive, Therapeutic
FormOral, Injectable, Topical, Implantable
Material TypeLatex, Non-Latex, Polyurethane
End UserHospitals, Clinics, Homecare

The contraceptives market is characterized by a dynamic landscape of market share distribution, competitive pricing strategies, and a surge in innovative product launches. The sector is witnessing robust growth, fueled by increased consumer awareness and evolving societal attitudes towards family planning. Companies are intensifying their efforts in research and development to introduce advanced contraceptive solutions, catering to diverse consumer needs. Pricing strategies remain competitive, with key players leveraging economies of scale to offer cost-effective options. The market is further buoyed by strategic collaborations and partnerships aimed at expanding product portfolios and enhancing market penetration. Competition within the contraceptives market is intense, with major players striving to differentiate through innovation and brand positioning. Regulatory frameworks across various regions significantly influence market dynamics, with stringent guidelines ensuring product safety and efficacy. The landscape is shaped by a few dominant players, yet new entrants are making notable inroads. Regulatory bodies in North America and Europe continue to set stringent standards, impacting product approval timelines and market entry strategies. The market is poised for sustained growth, driven by technological advancements and increasing demand for personalized contraceptive options.

Geographical Overview:

The contraceptives market is witnessing varied growth dynamics across different regions, with emerging opportunities in several countries. North America remains a dominant player, driven by increased awareness and the availability of advanced contraceptive methods. The region's robust healthcare infrastructure supports market expansion. Europe also demonstrates strong growth, buoyed by government initiatives promoting family planning and reproductive health. Asia Pacific is a burgeoning market, with rapid urbanization and rising disposable incomes contributing to increased demand for contraceptives. Countries like India and China are at the forefront, with significant investments in healthcare and education. Latin America is emerging as a promising market, with Brazil and Mexico leading due to progressive health policies and improved access to contraceptives. In the Middle East & Africa, there is a growing recognition of the importance of reproductive health, with countries like South Africa and Nigeria showing potential. Efforts to improve healthcare access and education are key drivers in these regions.

Global tariffs and geopolitical tensions are significantly influencing the contraceptives market, particularly in East Asia. Japan and South Korea are navigating these challenges by diversifying suppliers and investing in domestic pharmaceutical innovation to mitigate tariff impacts. China is focusing on self-reliance, enhancing its manufacturing capabilities to reduce dependency on international imports. Taiwan, a key player in pharmaceutical components, faces geopolitical risks that could disrupt supply chains. The global contraceptives market is experiencing steady growth, driven by increasing awareness and demand for reproductive health products. By 2035, the market is anticipated to evolve with advanced product offerings and improved accessibility. Middle East conflicts contribute to volatile energy prices, indirectly affecting manufacturing and distribution costs across the pharmaceutical industry, including contraceptives.

Key Trends and Drivers:

The contraceptives market is experiencing robust growth fueled by rising awareness and demand for family planning and reproductive health. Increasing government initiatives and educational campaigns are promoting the use of contraceptives, enhancing accessibility and awareness among diverse populations. The emergence of innovative contraceptive technologies, including long-acting reversible contraceptives, is catering to the evolving preferences of consumers seeking convenience and efficacy. Moreover, the growing emphasis on women's health and empowerment is driving the adoption of contraceptives, as women seek greater control over their reproductive choices. The market is witnessing a shift towards non-hormonal contraceptive options, reflecting consumer demand for safer and more natural alternatives. In addition, the expansion of telemedicine and digital health platforms is facilitating easier access to contraceptive products and consultations, particularly in remote areas. Opportunities abound in emerging economies where increasing urbanization and changing lifestyles are driving demand for contraceptive solutions. Companies that focus on affordability and accessibility are well-positioned to capture significant market share. Furthermore, partnerships with healthcare providers and NGOs can enhance distribution networks and outreach efforts, ensuring broader access to contraceptive options. The market's trajectory is poised for continuous growth, supported by technological advancements and a global focus on reproductive health and rights.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Form
  • 2.7 Key Market Highlights by Material Type
  • 2.8 Key Market Highlights by End User

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Hormonal
    • 4.1.2 Barrier
    • 4.1.3 Intrauterine
    • 4.1.4 Sterilization
    • 4.1.5 Natural
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Condoms
    • 4.2.2 Oral Contraceptive Pills
    • 4.2.3 Injectables
    • 4.2.4 Implants
    • 4.2.5 Intrauterine Devices (IUDs)
    • 4.2.6 Emergency Contraceptives
    • 4.2.7 Vaginal Rings
    • 4.2.8 Patches
    • 4.2.9 Spermicides
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Family Planning Services
    • 4.3.2 Counseling Services
    • 4.3.3 Educational Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Long-acting Reversible Contraceptives (LARC)
    • 4.4.2 Short-acting Hormonal Methods
    • 4.4.3 Permanent Methods
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Preventive
    • 4.5.2 Therapeutic
  • 4.6 Market Size & Forecast by Form (2020-2035)
    • 4.6.1 Oral
    • 4.6.2 Injectable
    • 4.6.3 Topical
    • 4.6.4 Implantable
  • 4.7 Market Size & Forecast by Material Type (2020-2035)
    • 4.7.1 Latex
    • 4.7.2 Non-Latex
    • 4.7.3 Polyurethane
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Hospitals
    • 4.8.2 Clinics
    • 4.8.3 Homecare

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Form
      • 5.2.1.7 Material Type
      • 5.2.1.8 End User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Form
      • 5.2.2.7 Material Type
      • 5.2.2.8 End User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Form
      • 5.2.3.7 Material Type
      • 5.2.3.8 End User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Form
      • 5.3.1.7 Material Type
      • 5.3.1.8 End User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Form
      • 5.3.2.7 Material Type
      • 5.3.2.8 End User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Form
      • 5.3.3.7 Material Type
      • 5.3.3.8 End User
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Form
      • 5.4.1.7 Material Type
      • 5.4.1.8 End User
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Form
      • 5.4.2.7 Material Type
      • 5.4.2.8 End User
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Form
      • 5.4.3.7 Material Type
      • 5.4.3.8 End User
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Form
      • 5.4.4.7 Material Type
      • 5.4.4.8 End User
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Form
      • 5.4.5.7 Material Type
      • 5.4.5.8 End User
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Form
      • 5.4.6.7 Material Type
      • 5.4.6.8 End User
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Form
      • 5.4.7.7 Material Type
      • 5.4.7.8 End User
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Form
      • 5.5.1.7 Material Type
      • 5.5.1.8 End User
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Form
      • 5.5.2.7 Material Type
      • 5.5.2.8 End User
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Form
      • 5.5.3.7 Material Type
      • 5.5.3.8 End User
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Form
      • 5.5.4.7 Material Type
      • 5.5.4.8 End User
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Form
      • 5.5.5.7 Material Type
      • 5.5.5.8 End User
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Form
      • 5.5.6.7 Material Type
      • 5.5.6.8 End User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Form
      • 5.6.1.7 Material Type
      • 5.6.1.8 End User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Form
      • 5.6.2.7 Material Type
      • 5.6.2.8 End User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Form
      • 5.6.3.7 Material Type
      • 5.6.3.8 End User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Form
      • 5.6.4.7 Material Type
      • 5.6.4.8 End User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Form
      • 5.6.5.7 Material Type
      • 5.6.5.8 End User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Reckitt Benckiser Group
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Church & Dwight
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Mayer Laboratories
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Mankind Pharma
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Cupid Limited
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Fuji Latex Co Ltd
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 HLL Lifecare Limited
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Veru Inc
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Okamoto Industries
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Ansell Limited
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Sagami Rubber Industries
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Karex Berhad
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Thai Nippon Rubber Industry
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Bio Film Inc
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Shanghai Dahua Medical Apparatus
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Sir Richard's Condom Company
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 RFSU AB
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Caya
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Bexen Medical
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Lelo
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us